SUBSTITUTED 4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRAZINE DERIVATIVES AS CASEIN KINASE 1 D/E INHIBITORS
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20160311824A1
公开(公告)日:2016-10-27
The invention provides compounds of Formula (I):
and pharmaceutically acceptable salts thereof. The compounds of Formula (I) inhibit protein kinase activity thereby making them useful as anticancer agents.